長期投資家のためのIR情報
 バリュートレンド
  1. HOME
  2. バリュートレンド
  3. 【4563】アンジェス

【4563】アンジェス
創薬。本社は大阪府。
類似企業：


東証グロース
医薬
＞
医他
売上高
営業利益
経常利益
当期利益
{{models[key].tabname}}
決算期 日付 予・実 売上高
(百万円)		 対前回 修正率 修正率 営業利益
(百万円)		 対前回 修正率 修正率 経常利益
(百万円)		 対前回 修正率 修正率 当期利益
(百万円)		 対前回 修正率 修正率
2026.12 2026/08/14 Q2予 1,330 → 0.0% 0.0% -10,230 → 0.0% 0.0% -10,240 → 0.0% 0.0% -10,250 → 0.0% 0.0%
2026.12 2026/05/08 Q1予 1,330 → 0.0% 0.0% -10,230 → 0.0% 0.0% -10,240 → 0.0% 0.0% -10,250 → 0.0% 0.0%
2026.12 2026/02/10 当初予 1,330 - - - -10,230 - - - -10,240 - - - -10,250 - - -
2025.12 2026/02/10 実 874 ↓ -0.7% -35.3% -5,145 ↑ +17.9% +11.3% -5,288 ↑ +15.9% +9.1% -5,123 ↑ +18.9% +12.4%
2025.12 2025/11/07 Q3予 880 → 0.0% -34.8% -6,270 → 0.0% -8.1% -6,290 → 0.0% -8.1% -6,320 → 0.0% -8.0%
2025.12 2025/10/27 修正予 880 ↓ -34.8% -34.8% -6,270 ↓ -8.1% -8.1% -6,290 ↓ -8.1% -8.1% -6,320 ↓ -8.0% -8.0%
2025.12 2025/08/08 Q2予 1,350 → 0.0% 0.0% -5,800 → 0.0% 0.0% -5,820 → 0.0% 0.0% -5,850 → 0.0% 0.0%
2025.12 2025/05/09 Q1予 1,350 → 0.0% 0.0% -5,800 → 0.0% 0.0% -5,820 → 0.0% 0.0% -5,850 → 0.0% 0.0%
2025.12 2025/02/14 当初予 1,350 - - - -5,800 - - - -5,820 - - - -5,850 - - -
2024.12 2025/02/14 実 643 ↑ +7.2% +21.3% -9,109 ↓ -7.8% -7.2% -7,537 ↑ +10.8% +11.3% -28,128 ↓ -225.2% -223.3%
2024.12 2024/11/08 Q3予 600 → 0.0% +13.2% -8,450 → 0.0% +0.6% -8,450 → 0.0% +0.6% -8,650 → 0.0% +0.6%
2024.12 2024/08/09 Q2予 600 → 0.0% +13.2% -8,450 → 0.0% +0.6% -8,450 → 0.0% +0.6% -8,650 → 0.0% +0.6%
2024.12 2024/05/10 Q1予 600 → 0.0% +13.2% -8,450 → 0.0% +0.6% -8,450 → 0.0% +0.6% -8,650 → 0.0% +0.6%
2024.12 2024/03/14 修正予 600 ↑ +13.2% +13.2% -8,450 ↑ +0.6% +0.6% -8,450 ↑ +0.6% +0.6% -8,650 ↑ +0.6% +0.6%
2024.12 2024/02/22 FY予 530 → 0.0% 0.0% -8,500 → 0.0% 0.0% -8,500 → 0.0% 0.0% -8,700 → 0.0% 0.0%
2024.12 2024/02/09 当初予 530 - - - -8,500 - - - -8,500 - - - -8,700 - - -
2023.12 2024/02/22 実 152 → 0.0% -20.0% -11,967 → 0.0% +22.8% -5,651 → 0.0% +42.9% -7,437 ↓ -5.7% +25.6%
2023.12 2024/02/09 実 152 ↓ -20.0% -20.0% -11,967 ↑ +11.4% +22.8% -5,651 ↑ +24.7% +42.9% -7,036 ↑ +6.2% +29.6%
2023.12 2023/11/08 Q3予 190 → 0.0% 0.0% -13,500 → 0.0% +12.9% -7,500 → 0.0% +24.2% -7,500 → 0.0% +25.0%
2023.12 2023/08/09 Q2予 190 → 0.0% 0.0% -13,500 ↑ +12.9% +12.9% -7,500 ↑ +24.2% +24.2% -7,500 ↑ +25.0% +25.0%
2023.12 2023/05/10 Q1予 190 → 0.0% 0.0% -15,500 → 0.0% 0.0% -9,900 → 0.0% 0.0% -10,000 → 0.0% 0.0%
2023.12 2023/02/10 当初予 190 - - - -15,500 - - - -9,900 - - - -10,000 - - -
2022.12 2023/02/10 実 67 - - - -16,316 - - - -14,610 - - - -14,714 - - -
2021.12 2022/02/10 実 64 - - - -15,632 - - - -13,588 - - - -13,675 - - -
2020.12 2021/02/15 実 39 - - - -5,599 - - - -6,618 - - - -4,209 - - -
2019.12 2020/02/03 実 326 ↓ -2.7% -2.7% -3,270 ↑ +0.9% -16.8% -3,293 ↑ +0.2% -17.6% -3,750 ↑ +0.3% -33.9%
2019.12 2020/01/23 修正予 335 → 0.0% 0.0% -3,300 → 0.0% -17.9% -3,300 → 0.0% -17.9% -3,760 ↓ -1.6% -34.3%
2019.12 2019/10/28 Q3予 335 → 0.0% 0.0% -3,300 ↓ -17.9% -17.9% -3,300 ↓ -17.9% -17.9% -3,700 ↓ -32.1% -32.1%
2019.12 2019/07/29 Q2予 335 → 0.0% 0.0% -2,800 → 0.0% 0.0% -2,800 → 0.0% 0.0% -2,800 → 0.0% 0.0%
2019.12 2019/04/22 Q1予 335 → 0.0% 0.0% -2,800 → 0.0% 0.0% -2,800 → 0.0% 0.0% -2,800 → 0.0% 0.0%
2019.12 2019/02/01 当初予 335 - - - -2,800 - - - -2,800 - - - -2,800 - - -
2018.12 2019/02/01 実 610 ↑ +1.7% +67.1% -3,065 ↑ +1.1% -22.6% -3,096 ↑ +0.1% -23.8% -2,996 ↑ +3.4% -19.8%
2018.12 2018/10/29 Q3予 600 → 0.0% +64.4% -3,100 → 0.0% -24.0% -3,100 → 0.0% -24.0% -3,100 → 0.0% -24.0%
2018.12 2018/08/27 修正予 600 ↑ +64.4% +64.4% -3,100 ↓ -24.0% -24.0% -3,100 ↓ -24.0% -24.0% -3,100 ↓ -24.0% -24.0%
2018.12 2018/07/30 Q2予 365 → 0.0% 0.0% -2,500 → 0.0% 0.0% -2,500 → 0.0% 0.0% -2,500 → 0.0% 0.0%
2018.12 2018/04/23 Q1予 365 → 0.0% 0.0% - - - - -2,500 → 0.0% 0.0% -2,500 → 0.0% 0.0%
2018.12 2018/02/02 当初予 365 - - - -2,500 - - - -2,500 - - - -2,500 - - -
2017.12 2018/02/02 実 365 ↑ +1.4% +1.4% -3,288 ↑ +0.4% +3.3% -3,307 ↓ -0.2% +2.7% -3,764 ↓ -0.1% -10.7%
2017.12 2018/01/22 修正予 360 → 0.0% 0.0% -3,300 ↑ +2.9% +2.9% -3,300 ↑ +2.9% +2.9% -3,760 ↓ -10.6% -10.6%
2017.12 2017/10/30 Q3予 360 → 0.0% 0.0% -3,400 → 0.0% 0.0% -3,400 → 0.0% 0.0% -3,400 → 0.0% 0.0%
2017.12 2017/07/31 Q2予 360 → 0.0% 0.0% -3,400 → 0.0% 0.0% -3,400 → 0.0% 0.0% -3,400 → 0.0% 0.0%
2017.12 2017/04/24 Q1予 360 → 0.0% 0.0% -3,400 → 0.0% 0.0% -3,400 → 0.0% 0.0% -3,400 → 0.0% 0.0%
2017.12 2017/02/03 当初予 360 - - - -3,400 - - - -3,400 - - - -3,400 - - -
2016.12 2017/02/03 実 514 ↑ +2.8% +28.5% -4,763 ↑ +8.4% +25.6% -4,847 ↑ +6.8% +24.3% -4,776 ↑ +8.2% +25.4%
2016.12 2016/12/06 修正予 500 ↑ +25.0% +25.0% -5,200 ↑ +18.8% +18.8% -5,200 ↑ +18.8% +18.8% -5,200 ↑ +18.8% +18.8%
2016.12 2016/08/01 Q2予 400 → 0.0% 0.0% -6,400 → 0.0% 0.0% -6,400 → 0.0% 0.0% -6,400 → 0.0% 0.0%
2016.12 2016/04/25 Q1予 400 → 0.0% 0.0% -6,400 → 0.0% 0.0% -6,400 → 0.0% 0.0% -6,400 → 0.0% 0.0%
2016.12 2016/02/05 当初予 400 - - - -6,400 - - - -6,400 - - - -6,400 - - -
2015.12 2016/02/05 実 430 ↓ -4.4% -4.4% -4,171 ↑ +3.0% +28.1% -4,089 ↑ +3.8% +29.5% -4,143 ↑ +3.7% +28.6%
2015.12 2015/10/30 Q3予 450 → 0.0% 0.0% -4,300 ↑ +25.9% +25.9% -4,250 ↑ +26.7% +26.7% -4,300 ↑ +25.9% +25.9%
2015.12 2015/08/03 Q2予 450 → 0.0% 0.0% -5,800 → 0.0% 0.0% -5,800 → 0.0% 0.0% -5,800 → 0.0% 0.0%
2015.12 2015/04/27 Q1予 450 → 0.0% 0.0% -5,800 → 0.0% 0.0% -5,800 → 0.0% 0.0% -5,800 → 0.0% 0.0%
2015.12 2015/02/06 当初予 450 - - - -5,800 - - - -5,800 - - - -5,800 - - -
2014.12 2015/02/06 実 909 ↑ +1.0% +13.6% -2,273 ↑ +5.3% +9.1% -2,395 ↑ +0.2% +4.2% -2,369 ↑ +1.3% +5.2%
2014.12 2015/02/02 修正予 900 ↑ +12.5% +12.5% -2,400 ↑ +4.0% +4.0% -2,400 ↑ +4.0% +4.0% -2,400 ↑ +4.0% +4.0%
2014.12 2014/10/27 Q3予 800 → 0.0% 0.0% -2,500 → 0.0% 0.0% -2,500 → 0.0% 0.0% -2,500 → 0.0% 0.0%
2014.12 2014/08/07 Q2予 800 → 0.0% 0.0% -2,500 → 0.0% 0.0% -2,500 → 0.0% 0.0% -2,500 → 0.0% 0.0%
2014.12 2014/05/09 Q1予 800 → 0.0% 0.0% -2,500 → 0.0% 0.0% -2,500 → 0.0% 0.0% -2,500 → 0.0% 0.0%
2014.12 2014/02/07 当初予 800 - - - -2,500 - - - -2,500 - - - -2,500 - - -
2013.12 2014/02/07 実 491 - - - -1,363 - - - -1,383 - - - -1,409 - - -
シェア ツイート
ページトップへ戻る